Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin for Corneal Epithelial Healing After Crosslinking
NCT06601101Phase 3Recruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Aug 2024
- Primary completion
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin in Corneal epithelial defect, sponsored by Universidade Estadual de Campinas. Started Aug 2024; status: recruiting.
02
Drugs
human insulin
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on NCT06601101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06601101.